ET6-26026-27929
4 vaccinations
4 coded responses
40 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 750 / TX
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2021-01-02
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-17
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-02
- 2021-10-04
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
-
2021-12-31
Survey response — 3 months, dose 3MedDRA: Diarrhoea, Magnetic resonance imaging abnormal, Mass, Oedema peripheral — Feeling: GoodFree text: Diarrhea for two days Lower leg edema with MRI findings of mass with upcoming appointment with specialist in sarcomaMedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Survey response — 6 months, dose 3MedDRA: Pleomorphic liposarcoma, Radiotherapy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Pleomorphic liposarcoma with current radiation treatment and future surgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-05-14
Dose 4 — Pfizer-BioNTech
- 2022-05-15
- 2022-05-17
- 2022-05-19
- 2022-05-20
- 2022-05-23
- 2022-05-28
-
2022-06-04
Survey response — day 21, dose 4MedDRA: Blood glucose increased, Pleomorphic liposarcoma, Procedural pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Above the knee amputation for paleomorphic liposarcoma on 05.31.2022 with associated postoperative pain and excessive glucose.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-11
- 2022-06-18
- 2022-06-25
- 2022-08-13
-
2022-11-12
Survey response — 6 months, dose 4MedDRA: Chemotherapy, Hospitalisation, Pyrexia, Tremor — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Chemotherapy first round followed in one week of uncontrollable tremors & high fever resolved with antibiotics with hospitalizationMedDRA releases: 2024-11 · check-in free text available
-
2022-11-12
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-11-14
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-05-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-05-14 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — 3 months, dose 3
Symptoms: Diarrhea for two days Lower leg edema with MRI findings of mass with upcoming appointment with specialist in sarcoma
Release 11 — 6 months, dose 3
Symptoms: Pleomorphic liposarcoma with current radiation treatment and future surgery
Release 11 — day 21, dose 4
Symptoms: Above the knee amputation for paleomorphic liposarcoma on 05.31.2022 with associated postoperative pain and excessive glucose.
Release 12 — 6 months, dose 4
Symptoms: Chemotherapy first round followed in one week of uncontrollable tremors & high fever resolved with antibiotics with hospitalization
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood glucose increased | · | · | ✓ |
| SD | Chemotherapy | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Magnetic resonance imaging abnormal | · | · | ✓ |
| SD | Mass | · | · | ✓ |
| SD | Oedema peripheral | · | · | ✓ |
| SD | Pleomorphic liposarcoma | · | · | ✓ |
| SD | Procedural pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Radiotherapy | · | · | ✓ |
| SD | Tremor | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release